S
Salarius Pharmaceuticals D
D
SLRX
0.62510
USD
-0.01
(-1.98%)
مغلق
حجم التداول
143,536
الربح لكل سهم
-188
العائد الربحي
-
P/E
-0
حجم السوق
1,329,766
الأخبار المقالات
العنوان: Salarius Pharmaceuticals Inc.
القطاع: Healthcare
الصناعة: Biotechnology
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.